Press Release: FILAMENT HEALTH ANNOUNCES CEO YEAR END LETTER AND CHANGE TO BOARD OF DIRECTORS
CANNANNEW REPORT

VANCOUVER, BC, Dec. 30, 2022 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced the distribution of a year-end letter from Chief Executive Officer, Benjamin Lightburn, which can be viewed on Filament’s website. The letter highlights key milestones achieved by the Company including beginning the first […]

Excerpt only …
READ MORE BELOW
Source : Press Release: FILAMENT HEALTH ANNOUNCES CEO YEAR END LETTER AND CHANGE TO BOARD OF DIRECTORS

reposted by Cannabis News World